Schedule 13G ownership disclosure

Enanta Pharmaceuticals Inc

Security class unavailable · CUSIP: 29251M106

Event date: 2014-03-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,541,078
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-019958
Form type
SC 13G
Filer
ENANTA PHARMACEUTICALS INC
CIK
CIK 1177648
Filed
Apr 01, 2014
Reporting period
Mar 26, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub